tadalafil has been researched along with tamsulosin in 48 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (tamsulosin) | Trials (tamsulosin) | Recent Studies (post-2010) (tamsulosin) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 1,460 | 468 | 693 |
| Protein | Taxonomy | tadalafil (IC50) | tamsulosin (IC50) |
|---|---|---|---|
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0008 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0013 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0045 | |
| Alpha-1D adrenergic receptor | Mus musculus (house mouse) | 0.0018 | |
| Alpha-1B adrenergic receptor | Mus musculus (house mouse) | 0.0018 | |
| Alpha-1A adrenergic receptor | Mus musculus (house mouse) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (6.25) | 29.6817 |
| 2010's | 27 (56.25) | 24.3611 |
| 2020's | 18 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bedding, A; Emmick, JT; Jackson, G; Kloner, RA; Mitchell, MI; Pereira, A; Warner, MR | 1 |
| Darstein, C; Guillaume, M; Jimenez, MC; Lonsdale, F; Mitchell, MI | 1 |
| Bechara, A; Casabé, A; Dedola, P; Haime, S; Hernández, C; Rey, H; Romano, S | 1 |
| Cox, D; Giuliano, F; Mirone, V; Oelke, M; Viktrup, L; Xu, L | 1 |
| Chapple, CR | 1 |
| Allona, A; Angulo, J; Cuevas, P; Fernández, A; La Fuente, JM; Moncada, I; Sáenz de Tejada, I | 1 |
| Imaoka, T; Kim, SC; Morisaki, Y; Viktrup, L; Wang, CJ; Yokoyama, O; Yoshida, M | 1 |
| Gacci, M | 1 |
| Cerqueira, JB; de Moraes, MO; Jamacaru, FV; Josino, IR; Nogueira, EA; Regadas, RP; Reges, R; Silva, LF; Sucupira, DG | 1 |
| Cox, D; Giuliano, F; Hatzimouratidis, K; Jungwirth, A; Oelke, M; Viktrup, L; Watts, S | 1 |
| Mandal, AK; Mete, UK; Singh, DV; Singh, SK | 1 |
| Baygani, SK; Giuliano, F; Melby, T; Oelke, M; Sontag, A | 1 |
| Agrawal, R; Agrawal, S; Jayant, K | 1 |
| Agrawal, MM; Agrawal, S; Jayant, K; Kumar, S; Parmar, KM; Singh, SK | 1 |
| De Nunzio, C; Tubaro, A | 1 |
| Acharya, GB; Basnet, RB; Kc, HB; Shah, AK; Shrestha, A; Shrestha, PM | 1 |
| Fallah-Karkan, M; Hassanzadeh-Hadad, A; Karami, H | 1 |
| García-Perdomo, HA; Montes Cardona, CE | 1 |
| Bai, Y; Han, P; Tang, Y; Wang, J; Wang, X; Yang, Y | 1 |
| Ahn, TY; Hyun, JS; Jung, J; Kim, SW; Lee, SW; Min, KS; Moon, DG; Moon, KH; Park, JK; Park, K; Park, NC; Ryu, JK; Son, H; Yang, DY; Yang, SK | 1 |
| Egawa, S; Furuta, A; Igarashi, T; Koike, Y; Suzuki, Y; Yoshimura, N | 1 |
| Afsar Yildirim, M; Akdeniz, F; Bozkurt, O; Çelik, S; Demir, O; Gursoy Bulut, M; Hacihasanoglu, ML | 1 |
| Ameli, M; Ameli, Z; Baghani Aval, H | 1 |
| Kaplan, SA | 1 |
| Dai, Y; Jiann, BP; Li, H; Li, P; Lou, Y; Park, HJ; Viktrup, L; Ye, Z; Zhang, X; Zhang, Z | 1 |
| Kitta, T | 1 |
| Bao, YG; Bi, SW; Jin, K; Li, JK; Liao, XY; Qiu, S; Tu, X; Wei, Q; Yang, L; Zheng, XN | 1 |
| Fujimura, M; Fukui, T; Oka, M; Oyama, T; Yoshifuji, M; Yoshinaga, R | 1 |
| Akamatsu, S; Goto, T; Kobayashi, T; Matsubara, K; Matsui, Y; Negoro, H; Ogawa, O; Omura, T; Terada, N; Yamamoto, T; Yonezawa, A | 1 |
| Chapple, C; De Nunzio, C; Frizzi, J; Gacci, M; Gravas, S; Kaplan, SA; Maggi, M; McVary, KT; Saleh, O; Sebastianelli, A; Serni, S; Spatafora, P; Tubaro, A; Vignozzi, L | 1 |
| Rezk, MR; Tantawy, MA; Wadie, M; Weshahy, SA | 2 |
| Ahn, ST; Jeong, HG; Kim, JW; Lee, DH; Moon, DG; Oh, MM; Park, HS | 1 |
| Cai, Z; Li, H; Ma, C; Zhang, J | 1 |
| Huang, H; Huang, WP; Ye, XT; Zhang, FY | 1 |
| Cai, Z; Li, H; Ma, C; Xiong, J; Zhang, J | 1 |
| Chen, X; Guo, B; Hou, H; Liu, M; Wang, M; Zhang, Z | 1 |
| Gupta, S; Singh, I; Tk, A | 1 |
| Chapple, C; Gacci, M; Gravas, S; Kaplan, S; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L | 1 |
| Chapple, C; Gacci, M; Gemma, L; Gravas, S; Kaplan, SA; Liaci, A; Maggi, M; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L; Zaccaro, C | 1 |
| Akdeniz, E; Caliskan, ST; Gur, M; Ozturk, K; Ulu, MB | 1 |
| Abdelhafez, AM; Gawad, DA; Hassan, EM; M Youssef, R | 1 |
| Matsuo, T; Miyata, Y; Sakai, H | 1 |
| Abdel Moneim, MM | 1 |
| Exintaris, B; Middendorff, R; Mietens, A; Seidensticker, M; Tasch, S | 1 |
| Abdelaal, MA; El-Dydamony, EM | 1 |
| Annadurai, S; Balavendra, A; Dangi, AD; Devasia, A; Kumar, S; Mukha, RP; Rajendran, G; Sadanala, ME; Singh, JC | 1 |
8 review(s) available for tadalafil and tamsulosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.
Topics: Acetylcholine Release Inhibitors; Botulinum Toxins, Type A; Drug Combinations; Humans; Laser Therapy; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatism; Solifenacin Succinate; Sulfonamides; Tadalafil; Tamsulosin; Transurethral Resection of Prostate; Urological Agents | 2015 |
Efficacy of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi: A systematic review and meta-analysis.
Topics: Analgesia; Humans; Phosphodiesterase 5 Inhibitors; Sulfonamides; Tadalafil; Tamsulosin; Ureteral Calculi; Urological Agents | 2017 |
Tadalafil Facilitates the Distal Ureteral Stone Expulsion: A Meta-Analysis.
Topics: Humans; Pain Measurement; Sulfonamides; Tadalafil; Tamsulosin; Ureteral Calculi; Urological Agents | 2017 |
Efficacy and safety of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi of 5 to 10 mm in size: A systematic review and network meta-analysis.
Topics: Bayes Theorem; Drug Therapy, Combination; Female; Humans; Male; Network Meta-Analysis; Phosphodiesterase 5 Inhibitors; Randomized Controlled Trials as Topic; Tadalafil; Tamsulosin; Treatment Outcome; Ureteral Calculi; Urological Agents | 2019 |
Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis.
Topics: Bayes Theorem; Databases, Factual; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Network Meta-Analysis; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Safety; Sildenafil Citrate; Tadalafil; Tamsulosin; Treatment Outcome | 2020 |
Comparative Effectiveness of Tadalafil versus Tamsulosin in Treating Lower Urinary Tract Symptoms Suggestive of Benign Prostate Hyperplasia: A Meta-Analysis of Randomized Controlled Trials.
Topics: Adrenergic alpha-1 Receptor Antagonists; Double-Blind Method; Drug Therapy, Combination; Humans; Hyperplasia; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Tadalafil; Tamsulosin; Treatment Outcome | 2020 |
Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED.
Topics: Combined Modality Therapy; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2020 |
23 trial(s) available for tadalafil and tamsulosin
| Article | Year |
|---|---|
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Aged; Carbolines; Cross-Over Studies; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Doxazosin; Drug Interactions; Hemodynamics; Humans; Male; Middle Aged; Phosphoric Diester Hydrolases; Sulfonamides; Tadalafil; Tamsulosin | 2004 |
Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Carbolines; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Interactions; Drug Therapy, Combination; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Sulfonamides; Tadalafil; Tamsulosin | 2007 |
Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study.
Topics: Aged; Carbolines; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Retention | 2008 |
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Carbolines; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Vasodilator Agents | 2012 |
Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
Topics: Administration, Oral; Aged; Analysis of Variance; Carbolines; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Selection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Reference Values; Risk Assessment; Severity of Illness Index; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urination; Urodynamics | 2013 |
Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled clinical trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Carbolines; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tadalafil; Tamsulosin; Urinary Bladder, Overactive; Urination; Urodynamics | 2013 |
Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Analysis of Variance; Carbolines; Double-Blind Method; Drug Administration Schedule; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Orgasm; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tadalafil; Tamsulosin | 2013 |
A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Retention | 2014 |
Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study.
Topics: Aged; Aged, 80 and over; Carbolines; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2014 |
Tamsulosin versus tamsulosin plus tadalafil as medical expulsive therapy for lower ureteric stones: a randomized controlled trial.
Topics: Adult; Carbolines; Drug Therapy, Combination; Ejaculation; Female; Humans; Male; Middle Aged; Penile Erection; Renal Colic; Sulfonamides; Tadalafil; Tamsulosin; Time Factors; Ureteral Calculi; Urological Agents; Young Adult | 2014 |
Role of tamsulosin, tadalafil, and silodosin as the medical expulsive therapy in lower ureteric stone: a randomized trial (a pilot study).
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Carbolines; Double-Blind Method; Female; Humans; Indoles; Male; Phosphodiesterase 5 Inhibitors; Pilot Projects; Prospective Studies; Sulfonamides; Tadalafil; Tamsulosin; Ureteral Calculi | 2015 |
Tamsulosin versus tadalafil as a medical expulsive therapy for distal ureteral stones: A prospective randomized study.
Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Diclofenac; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pain Measurement; Prospective Studies; Renal Colic; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Ureteral Calculi; Urological Agents; Young Adult | 2016 |
Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tadalafil; Tamsulosin | 2016 |
Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
Topics: Aged; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2017 |
Effectiveness of the addition of tadalafil to tamsulosin in the treatment of acute urinary retention in patients with benign prostatic hyperplasia: A randomized clinical trial.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Retention | 2018 |
Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled s
Topics: Aged; China; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Placebos; Prostatic Hyperplasia; Republic of Korea; Severity of Illness Index; Tadalafil; Taiwan; Tamsulosin; Treatment Outcome | 2019 |
Add-on effects of tadalafil in tamsulosin-treated patients with small benign prostatic enlargement: A randomized, placebo-controlled, double-blind, crossover study.
Topics: Aged; Aged, 80 and over; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2020 |
[Therapeutic effect of tadalafil on lower urinary tract symptoms with erectile dysfunction].
Topics: Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Treatment Outcome | 2019 |
Efficacy and safety of tadalafil vs tamsulosin in lower urinary tract symptoms (LUTS) as a result of benign prostate hyperplasia (BPH)-open label randomised controlled study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents | 2020 |
Dexketoprofen vs. Tamsulosin vs. Silodosin vs. Tadalafil as Medical Expulsive Therapy for Distal Ureteral Stones in Men.
Topics: Adult; Cohort Studies; Humans; Indoles; Ketoprofen; Male; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Tromethamine; Turkey; Ureteral Calculi | 2021 |
Editorial Comment to Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial.
Topics: Double-Blind Method; Drug Therapy, Combination; Herbal Medicine; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Treatment Outcome | 2022 |
Comparative study between Tamsulosin, Silodosin and Tadalafil as a medical expulsive therapy for lower ureteral stones.
Topics: Adult; Female; Humans; Indoles; Male; Middle Aged; Prospective Studies; Tadalafil; Tamsulosin; Treatment Outcome; Ureteral Calculi; Urological Agents | 2023 |
Is low-dose tadalafil better than tamsulosin? A randomized controlled trial in shockwave lithotripsy for solitary upper tract calculi.
Topics: Humans; Lithotripsy; Prospective Studies; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Ureteral Calculi | 2023 |
17 other study(ies) available for tadalafil and tamsulosin
| Article | Year |
|---|---|
Monotherapy with α-blocker or phosphodiesterase 5 inhibitor for lower urinary tract symptoms?
Topics: Adrenergic alpha-1 Receptor Antagonists; Carbolines; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Vasodilator Agents | 2012 |
Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck.
Topics: Adrenergic alpha-1 Receptor Antagonists; Carbolines; Electric Stimulation; Humans; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase 5 Inhibitors; Prostate; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Urinary Bladder | 2012 |
Editorial Comment to tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
Topics: Carbolines; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin | 2013 |
Effects of combined treatment of tadalafil and tamsulosin on bladder dysfunction via the inhibition of afferent nerve activities in a rat model of bladder outlet obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Blood Pressure; Drug Therapy, Combination; Female; Muscle Contraction; Muscle, Smooth; Phosphodiesterase 5 Inhibitors; Rats; Sulfonamides; Tadalafil; Tamsulosin; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics | 2018 |
Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Doxazosin; Female; Flank Pain; Humans; Indoles; Male; Middle Aged; Quinazolines; Retrospective Studies; Tadalafil; Tamsulosin; Tomography, X-Ray Computed; Treatment Outcome; Ureteral Calculi; Urological Agents; Young Adult | 2018 |
Re: Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
Topics: Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin | 2018 |
Editorial Comment to Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and ta
Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin | 2019 |
Comparison of the Effects of Tadalafil and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Ejaculation; Electric Stimulation; Indoles; Male; Muscle Contraction; Naphthalenes; Phosphodiesterase 5 Inhibitors; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Seminal Vesicles; Tadalafil; Tamsulosin; Vas Deferens | 2019 |
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Urological Agents | 2021 |
Smart spectrophotometric assessment of tamsulosin hydrochloride and tadalafil in their new pharmaceutical formulation for treatment of benign prostatic hyperplasia and erectile dysfunction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Capsules; Drug Combinations; Drug Compounding; Erectile Dysfunction; Humans; Limit of Detection; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Spectrophotometry; Tadalafil; Tamsulosin | 2020 |
Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction.
Topics: Age Factors; Aged; Drug Combinations; Erectile Dysfunction; Humans; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Prostatic Hyperplasia; Retrospective Studies; Tadalafil; Tamsulosin; Treatment Failure; Urological Agents | 2020 |
To evaluate the efficacy and safety of different kinds of PDE5-Is with tamsulosin as a medical therapy for LUTS secondary to benign prostatic hyperplasia: A protocol for systematic review and meta analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Bayes Theorem; Drug Therapy, Combination; Humans; Male; Meta-Analysis as Topic; Network Meta-Analysis; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Research Design; Sildenafil Citrate; Systematic Review as Topic; Tadalafil; Tamsulosin; Vardenafil Dihydrochloride | 2020 |
Novel HPTLC densitometric methods for determination of tamsulosin HCl and tadalafil in their newly formulated dosage form: Comparative study and green profile assessment.
Topics: Capsules; Chromatography, Thin Layer; Densitometry; Green Chemistry Technology; Limit of Detection; Linear Models; Reproducibility of Results; Tadalafil; Tamsulosin | 2020 |
Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome.
Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin | 2021 |
Assay of new combination of tamsulosin and tadalafil using synchronous spectrofluorimetric method coupled with mathematical tools.
Topics: Drug Therapy, Combination; Humans; Prostatic Hyperplasia; Spectrometry, Fluorescence; Tadalafil; Tamsulosin | 2022 |
Green & Sensitive pH-dependent Spectrofluorimetric Assay of Tamsulosin Hydrochloride and Tadalafil in their New Combined Formulation for Benign Prostatic Hyperplasia: Application to Spiked Human Plasma.
Topics: Humans; Hydrogen-Ion Concentration; Male; Prostatic Hyperplasia; Spectrometry, Fluorescence; Tadalafil; Tamsulosin | 2022 |
Treatment of benign prostatic hyperplasia and abnormal ejaculation: live imaging reveals tamsulosin - but not tadalafil - induced dysfunction of prostate, seminal vesicles and epididymis.
Topics: Ejaculation; Epididymis; Humans; Male; Norepinephrine; Prostate; Prostatic Hyperplasia; Seminal Vesicles; Sulfonamides; Tadalafil; Tamsulosin | 2022 |